Elisabeth Ersvær

2.5k citations

58 papers · 1.3k indexed · h-index 24

Co-authors: Øystein Bruserud Bjørn Tore Gjertsen Anita Ryningen Kimberley Joanne Hatfield Håkon Reikvam Camilla Stapnes Astrid Olsnes Kittang Knut Liseth
Topics: Acute Myeloid Leukemia Research (19 papers)Immune Cell Function and Interaction (16 papers)Hematopoietic Stem Cell Transplantation (14 papers)
Cited by: Hematology Immunology Genetics
Journals: SHILAP Revista de lepidopterologíaAmerican Journal of Clinical Nutrition International Journal of Molecular Sciences
Partner nations: Norway United Kingdom United States

In The Last Decade

Elisabeth Ersvær

54 papers receiving 1.3k citations

Peers

Countries citing papers authored by Elisabeth Ersvær

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Ersvær's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Ersvær with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Ersvær more than expected).

Fields of papers citing papers by Elisabeth Ersvær

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Ersvær. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Ersvær. The network helps show where Elisabeth Ersvær may publish in the future.

Co-authorship network of co-authors of Elisabeth Ersvær

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Ersvær. A scholar is included among the top collaborators of Elisabeth Ersvær based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Ersvær. Elisabeth Ersvær is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Infant vitamin B12 status and its predictors – cross-sectional baseline results from an ongoing randomized controlled trial 2025 ·American Journal of Clinical Nutrition ·(unknown),(unknown),Carolien Konijnenberg,(unknown),(unknown),(unknown),Adrian McCann,Per Magne Ueland,Ingrid Kvestad,Elisabeth Ersvær,Mads Holten-Andersen,Kjersti Bakken,Tor A. Strand	0
2	Acute response in circulating microRNAs following a single bout of short-sprint and heavy strength training in well-trained cyclists 2024 ·Frontiers in Physiology ·Anita Ryningen,Kari Rostad,Elisabeth Ersvær,(unknown),Gøran Paulsen,Hilde Gundersen,Morten Kristoffersen,Lise Bjørkhaug	0
3	Vitamin B ₁₂ status in infancy and the effect of a vitamin B ₁₂ injection in infants with subclinical vitamin B ₁₂ deficiency: study protocol for a register-based randomised controlled trial 2023 ·BMJ Open ·Kjersti Bakken,Ingrid Kvestad,(unknown),(unknown),(unknown),Adrian McCann,Mads Holten-Andersen,Elisabeth Ersvær,Carolien Konijnenberg,Tor A. Strand	2
4	The Female Menstrual Cycles Effect on Strength and Power Parameters in High-Level Female Team Athletes 2021 ·Frontiers in Physiology ·(unknown),Morten Kristoffersen,Elisabeth Ersvær,(unknown),Lise Bjørkhaug,Rolf Moe‐Nilssen,Jørn V. Sagen,Inger Haukenes	32
5	Circulating monocyte subsets in multiple myeloma patients receiving autologous stem cell transplantation – a study of the preconditioning status and the course until posttransplant reconstitution for a consecutive group of patients 2019 ·BMC Immunology ·(unknown),Elisabeth Ersvær,Aymen Ahmed,Anita Ryningen,Øystein Bruserud	8
6	The healthy donor profile of immunoregulatory soluble mediators is altered by stem cell mobilization and apheresis 2018 ·Cytotherapy ·(unknown),Elisabeth Ersvær,Kristin Paulsen Rye,Aymen Ahmed,Einar K. Kristoffersen,Tor Hervig,Håkon Reikvam,Kimberley Joanne Hatfield,Øystein Bruserud	3
7	Standardization of sampling and sample preparation for analysis of human monocyte subsets in peripheral blood 2018 ·Journal of Immunological Methods ·(unknown),Øystein Bruserud,Anita Ryningen,Elisabeth Ersvær	17
8	Effects of cytarabine on activation of human T cells – cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acid 2015 ·BMC Pharmacology and Toxicology ·Elisabeth Ersvær,Annette K. Brenner,(unknown),Håkon Reikvam,Øystein Bruserud	25
9	Distinct single cell signal transduction signatures in leukocyte subsets stimulated with khat extract, amphetamine-like cathinone, cathine or norephedrine 2013 ·BMC Pharmacology and Toxicology ·(unknown),Elisabeth Ersvær,(unknown),André Sulen,Håkon Reikvam,Hans Jørgen Aarstad,Anne Christine Johannessen,Olav Karsten Vintermyr,Øystein Bruserud,Bjørn Tore Gjertsen	10
10	The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemia 2013 ·Clinical Epigenetics ·Hanne Fredly,Elisabeth Ersvær,Astrid Olsnes Kittang,Galina Tsykunova,Bjørn Tore Gjertsen,Øystein Bruserud	46
11	Expression profile of heat shock proteins in acute myeloid leukaemia patients reveals a distinct signature strongly associated with FLT3 mutation status – consequences and potentials for pharmacological intervention 2011 ·British Journal of Haematology ·Håkon Reikvam,Kimberley Joanne Hatfield,Elisabeth Ersvær,Randi Hovland,Jørn Skavland,Bjørn Tore Gjertsen,Kjell Petersen,(unknown)	38
12	Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation? 2011 ·Cancer Immunology Immunotherapy ·Elisabeth Ersvær,(unknown),Øystein Bruserud	18
13	Early pre-engraftment, functional, in vitro responsiveness of T lymphocytes in allotransplanted, acute leukemia patients: proliferation and release of a broad profile of cytokines, possibly predictive of graft-versus-host disease 2010 ·European Cytokine Network ·Knut Liseth,(unknown),(unknown),Øystein Bruserud,Elisabeth Ersvær	12
14	Flow Cytometry Study of Blood Cell Subtypes Reflects Autoimmune and Inflammatory Processes in Autoimmune Polyendocrine Syndrome Type I 2010 ·Scandinavian Journal of Immunology ·Anette S. B. Wolff,Bergithe E Oftedal,Kai Kisand,Elisabeth Ersvær,Kalil Alves de Lima,Eystein S. Husebye	36
15	Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells 2010 ·BMC Immunology ·Elisabeth Ersvær,Knut Liseth,Jørn Skavland,Bjørn Tore Gjertsen,Øystein Bruserud	62
16	Targeting the angiopoietin (Ang)/Tie-2 pathway in the crosstalk between acute myeloid leukaemia and endothelial cells: studies of Tie-2 blocking antibodies, exogenous Ang-2 and inhibition of constitutive agonistic Ang-1 release 2010 ·Expert Opinion on Investigational Drugs ·Håkon Reikvam,Kimberley Joanne Hatfield,Philippe Lassalle,Astrid Olsnes Kittang,Elisabeth Ersvær,Øystein Bruserud	37
17	In Vitro Induction of a Dendritic Cell Phenotype in Primary Human Acute Myelogenous Leukemia (AML) Blasts Alters the Chemokine Release Profile and Increases the Levels of T Cell Chemotactic CCL17 and CCL22 2008 ·Journal of Interferon & Cytokine Research ·(unknown),Anita Ryningen,Elisabeth Ersvær,Øystein Bruserud	12
18	Effects of interferon gamma on native human acute myelogenous leukaemia cells 2006 ·Cancer Immunology Immunotherapy ·Elisabeth Ersvær,Jørn Skavland,Elling Ulvestad,Bjørn Tore Gjertsen,Øystein Bruserud	27
19	Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2:Bax ratio and low levels of heat shock protein 70 and 90 2006 ·Leukemia Research ·Anita Ryningen,Elisabeth Ersvær,Anne M. Øyan,Karl‐Henning Kalland,Olav Karsten Vintermyr,Bjørn Tore Gjertsen,Øystein Bruserud	52
20	In vitro effects of native human acute myelogenous leukemia blasts on fibroblasts and osteoblasts 2004 ·International Journal of Cancer ·Nils Glenjen,Elisabeth Ersvær,Anita Ryningen,Øystein Bruserud	14

About Elisabeth Ersvær

Elisabeth Ersvær is a scholar working on Hematology, Immunology and Genetics, having authored 58 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), Immune Cell Function and Interaction (16 papers) and Hematopoietic Stem Cell Transplantation (14 papers). The work is most often cited by research in Hematology (584 citations), Immunology (412 citations) and Genetics (128 citations). Elisabeth Ersvær has collaborated with scholars based in Norway, United Kingdom and United States. Frequent co-authors include Øystein Bruserud, Bjørn Tore Gjertsen, Anita Ryningen, Kimberley Joanne Hatfield, Håkon Reikvam, Camilla Stapnes, Astrid Olsnes Kittang, Knut Liseth, Jørn Skavland and Peter Hampson. Their work appears in journals such as SHILAP Revista de lepidopterología, American Journal of Clinical Nutrition and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact